Christopher John Kenney insider trades
Open-market stock purchases and sales by Christopher John Kenney, Chief Medical Officer at Xenon Pharmaceuticals Inc, from SEC Form 4 filings since Aug 23, 2021.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +27%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 13, 2026 | XENE Xenon Pharmaceuticals Inc | Sold | $77.9K |
| Mar 12, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
| Mar 10, 2026 | XENE Xenon Pharmaceuticals Inc | Sold | $167K |
| Mar 9, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
| Mar 9, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
| Jan 9, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
| Jan 9, 2026 | XENE Xenon Pharmaceuticals Inc | Bought (not open market) | — |
Companies traded
- XENE Xenon Pharmaceuticals Inc: 1 buy, 3 sales, last Mar 13, 2026
Get free alerts when Christopher John Kenney files a new trade →